Pelthos Therapeutics Inc share price logo

Pelthos Therapeutics Inc Share Price

NYSE: PTHS

$22.75

-0.57

(-2.45%)

as on

Pelthos Therapeutics Inc Stock Performance

as on February 7, 2026 at 7:57 am IST

  • Day's Low

    Day's High

    $22.25
    $23.30
    downward going graph

    2.20%

    Downside

    2.42%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $13.76
    $54.29
    downward going graph

    39.52%

    Downside

    138.64%

    Upside

    downward going graph

Pelthos Therapeutics Inc share price movements today

Previous Close
$23.32
Open
$22.25
Volume
166.1K
Day's Low - High
$22.25 - $23.30
52 Week Low - High
$13.76 - $54.29

Pelthos Therapeutics Inc Historical Returns

1 Month Return
-17.89 %
3 Month Return
-33.17 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Pelthos Therapeutics Inc Stock Fundamentals & Key Indicators

Check Pelthos Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Pelthos Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pelthos Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Pelthos Therapeutics Inc image
Pelthos Therapeutics Inc
NA$-NANA0.00%
Insmed Incorporated image
Insmed Incorporated
BUY$34.7B252.94%-16.34-264.83%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$47.7B98.75%1246.031.36%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$122.3B122.02%33.5631.35%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.8B57.42%18.2832.13%

Pelthos Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Pelthos Therapeutics Inc Stock has decreased by -64% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-64% versus previous 30 day period

Pelthos Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
-
7
Gross Profit
-
-
-
-
-
-
4
Operating Income
-1
-1
-2
-1
-1
-3
-15
EBITDA
-1
-1
-1
-1
-1
-3
-14
Interest Expense
0
0
0
0
0
0
1
Depreciation
-
-
-
-
-
-
2
Income Before Tax
-2
-1
-1
-1
-1
-3
-16
Income Tax Expense
-
-
-
-
-
-
0
Net Income
-2
-1
-1
-1
-1
-3
-16
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-219.25%

Pelthos Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
-
-
-
-
Gross Profit
0
-
-
-
-
Operating Income
-1
0
-2
-6
-7
EBITDA
0
0
-2
-6
-7
Interest Expense
0
0
0
0
0
Depreciation
-
-
-
-
-
Income Before Tax
0
0
-2
-7
-7
Income Tax Expense
-
-
-
-
-
Net Income
0
0
-2
-7
-7
Net Profit Margin
-330.40%
0.00%
0.00%
0.00%
0.00%

Pelthos Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-2
-1
-1
-1
-1
-3
-16
Operating Cash Flow
-1
-2
0
0
0
0
-15
Investing Cash Flow
-
-
-
-
-
-
2
Financing Cash Flow
5
1
0
0
0
0
26
Change in Cash
3
-1
-1
0
0
0
14

Pelthos Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Net Income
-2
-7
-7
Operating Cash Flow
-1
0
-5
Investing Cash Flow
-
-
-
Financing Cash Flow
1
1
6
Change in Cash
0
0
0

Insights on Pelthos Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, PTHS stock has moved up by 3241.1%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PTHS has outperformed top 5 stocks with highest market-cap in its industry

About Pelthos Therapeutics Inc

Pelthos Therapeutics Inc. is a biopharmaceutical company focused on commercializing therapeutic products for unmet patient needs. The Company's lead product, ZELSUVMI (berdazimer) topical gel, 10.3%, is used in the treatment of molluscum contagiosum infections (molluscum) in adults and pediatric patients one year of age and older. In addition to ZELSUVMI, the Company has a pipeline of product candidates that utilize its proprietary nitric oxide-based technology platform, NITRICIL. The Company’s product Xepi is a quinolone antimicrobial indicated for the topical treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients two months of age and older. Its NaV 1.7 is a clinical-stage assets which selectively target the sodium ion-channel. The Company also Xeglyze, which is a is a pediculicide indicated for the topical treatment of head lice infestation in patients six months of age and older.
OrganisationPelthos Therapeutics Inc
Headquarters4020 Stirrup Creek Drive, Durham, NC, United States, 27703
CEOMr. Scott M. Plesha
E-voting on sharesClick here to vote

Key Management of Pelthos Therapeutics Inc

Name

Title

Mr. Sai Rangarao M.B.A.

Chief Commercial Officer

Mr. Francis Knuettel II, M.B.A.

CFO, Secretary & Treasurer

Mr. Scott M. Plesha

CEO, President & Director

FAQs

What is Pelthos Therapeutics Inc share price today?

Pelthos Therapeutics Inc share price today is $22.75 as on at the close of the market. Pelthos Therapeutics Inc share today touched a day high of $23.3 and a low of $22.25.

What is the 52 week high and 52 week low for Pelthos Therapeutics Inc share?

Pelthos Therapeutics Inc share touched a 52 week high of $54.29 on and a 52 week low of $13.76 on . Pelthos Therapeutics Inc stock price today i.e. is closed at $22.75,which is 58.10% down from its 52 week high and 65.33% up from its 52 week low.

How to invest in Pelthos Therapeutics Inc Stock (PTHS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pelthos Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pelthos Therapeutics Inc Shares that will get you 0.0659 shares as per Pelthos Therapeutics Inc share price of $22.75 per share as on February 7, 2026 at 2:27 am IST.

What is the minimum amount required to buy Pelthos Therapeutics Inc Stock (PTHS) from India?

Indian investors can start investing in Pelthos Therapeutics Inc (PTHS) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Pelthos Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Pelthos Therapeutics Inc share’s latest price of $22.75 as on February 7, 2026 at 2:27 am IST, you will get 0.4396 shares of Pelthos Therapeutics Inc. Learn more about fractional shares .